New Jersey Administrative Code › Title 8 - HEALTH › Chapter 39 - STANDARDS FOR LICENSURE OF LONG-TERM CARE FACILITIES › Subchapter 29 - MANDATORY PHARMACY › Section 8:39-29.3 - Mandatory pharmacy reporting policies and procedures

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The consultant
				pharmacist shall conduct a drug regimen review and enter appropriate comments into
				the medical record of every resident receiving medication, at least monthly, on a
				pharmacist consultation sheet or another portion of the medical record, in
				accordance with N.J.A.C. 13:39. The drug regimen review shall be performed in
				accordance with Federal and State statutes, rules and regulations, and currently
				accepted standards of practice for rational drug therapy.
1. The consultant pharmacist shall report any
				irregularities promptly to the attending physician or advanced practice nurse and to
				the director of nurses and these reports shall be acted upon. These reports shall
				include, but are not limited to, problems and recommendations about drug therapy
				which may be affected by biologicals, laboratory tests, special dietary requirements
				and foods used or administered concomitantly with other medication to the same
				recipient. Also, these reports are required to include monitoring for potential
				adverse effects, allergies, drug interactions, contraindications, rationale, and
				drug evaluation.
2. The consultant
				pharmacist shall report drug defects and adverse drug reactions, in accordance with
				the recommendations of the ASHSP-USP-FDA (American Society of Health System
				Pharmacists, United States Pharmacopeia, Food and Drug Administration) to the
				Adverse Event Reporting System.
i. Information on
				the Adverse Event Reporting System may be found at
http://www.fda.gov/safety/medical-product-safety-information/forms-reporting-fda
and reports may be filed electronically at
http://www.fda.gov/drugs/fda-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-electronic-submissions
.
3. All known drug allergies shall be
				documented in the resident's medical record including the medication administration
				records and physician or advanced practice nurse order sheets and on the outside
				front cover and communicated to the provider or dispensing pharmacy.
4. Drugs that are not specifically limited as to
				duration of use or number of doses shall be controlled by automatic stop orders. The
				resident's attending physician or advanced practice nurse shall be notified of the
				automatic stop order prior to the last dose so that he or she may decide whether to
				continue use of the drug.
5. If
				medication is withheld, the reason for withholding the medication shall be
				documented in the resident's medical record.
6. Medication errors and adverse drug reactions
				shall be reported immediately to the director of nursing or the alternate to the
				director of nursing, and a description of the error or adverse drug reaction shall
				be entered into the medical record before the end of the employee shift. If the
				resident has erroneously received medication, the resident's physician or advanced
				practice nurse shall be notified immediately. If a medication error originated in
				the pharmacy, the pharmacy shall be notified immediately. The Department shall be
				notified of an adverse drug reaction that results in death.